
Core Points - Amarin Corporation plc will host a conference call on July 30, 2025, at 8:00 a.m. ET to discuss its second quarter 2025 results and recent strategic steps [1][2] - The financial results will be released in the pre-market hours on the same day [2] Conference Call and Webcast Information - Access to the live call can be found on the investor relations section of Amarin's website, with specific dial-in numbers provided for both the United States and international participants [3] - A replay of the call will be available shortly after the live event through the company's website [3] Company Overview - Amarin is an innovative pharmaceutical company focused on cardiovascular disease management, with offices in multiple countries including the United States, Ireland, and Switzerland [4] - The company aims to enhance the scientific understanding of cardiovascular risk that persists beyond traditional therapies [4] Investor Communication - Amarin utilizes its website and investor relations section to communicate with investors and the public, providing access to various materials including presentations, SEC filings, and press releases [5] - The company encourages regular review of the information posted on these channels, which may include updates on social media [5]